Subtype
Intrahepatic Cholangiocarcinoma
CI-CAN-00002944ICC · ICCAExplore in graph →
88 active trials1 approved drugs8 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002944ICC · ICCAExplore in graph →
Clinical trials
227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (31)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07153783 | Interventional AI-Human Collaboration for Liver Tumor Diagnosis | completed | N/A | 10,333 | Shengjing HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT03796819 | Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma(LND for ICC) | completed | N/A | 260 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT01347333 | Stereotactic Body Radiotherapy for Liver Tumors | completed | N/A | 23 | Mercy ResearchOTHER | 1 | Mar 3, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Nov 18, 2025source: clinicaltrials